Search

everythinglearnresearchcommunity

for

Search:↓

The symposium highlighted the importance of understanding disease mechanisms for targeted dermatology treatments.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Lifestyle changes can improve skin health and reduce disease symptoms.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

HS patients rarely see dermatologists, often get opiates, and need better care.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

New treatments for acne scars are safer and more effective because we understand the causes better.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Dupilumab for eczema may cause hair loss.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Thyroid function affects skin health, with a complex interaction between the two.

Immune cells affect hair growth and could lead to new hair loss treatments.

Gray hair is caused by reduced melanin production or transfer issues, linked to aging and possibly health conditions, with treatments focusing on color camouflage.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.